Data analysis reveals a stable, cross-cohort female cancer mortality excess at ages 35-60, contrasting with female advantages in cardiovascular and external-cause mortality. Breast cancer drives the ...
Despite affecting half of the world's population, menopause has historically been understudied and misunderstood, both in biomedical research and clinical practice. However, with the increase in life ...